Scinovex
review Open AccessTop 1% cited

Cancer immunotherapy: Pros, cons and beyond

Biomedicine & Pharmacotherapy · 2020 · Vol. 124 · pp. 109821–109821
Shuzhen TanDongpei LiXiao Zhu

Abstract

Cancer immunotherapy is an innovative treatment for tumors today. In various experiments and clinical studies, it has been found that immunotherapy does have incomparable advantages over traditional anti-tumor therapy, which can prolong progression-free survival (PFS) and overall survival (OS). However, immunotherapy has obvious complexity and uncertainty. Immunotherapy may also cause severe adverse reactions due to an overactive immune system. More effective and fewer adverse reactions immunological checkpoints are still under further exploration. This review gives an overview of recent developments in immunotherapy and indicates a new direction of tumor treatment through analyzing the pros and cons of immunotherapy coupled with keeping a close watch on the development trend of the immunotherapy future.

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesImmune Cell Function and InteractionImmunotherapyMedicineCancer immunotherapyAdverse effectCancerOncologyInternal medicine

MeSH terms

Antineoplastic Agents, ImmunologicalDrug ResistanceHumansImmunotherapyKiller Cells, NaturalNeoplasmsImmunotherapy, Adoptive

Funding

  • National Natural Science Foundation of China
  • Guangdong Science and Technology Department
Citations
669
FWCI
27.28
field-weighted impact
References
95
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Cancer immunotherapy: Pros, cons and beyond · Scinovex